MDM4 is a rational target for treating breast cancers with mutant p53

Author(s):
Miranda, P.J.; Buckley, D.; Raghu, D.; Pang, J.M.B.; Takano, E.A.; Vijayakumaran, R.; Teunisse, A.F.A.S.; Posner, A.; Procter, T.; Herold, M.J.; Gamell, C.; Marine, J.C.; Fox, S.B.; Jochemsen, A.; Haupt, S.; Haupt, Y.
Published
2017
Publication type
Article / Letter to editor
MDM4breast cancermutant p53p27TNBC
Date issued
2017-04-30
Language
English
Is part of
Journal of Pathology (2017), Vol. 241, no. 5, p. 661-670
hdl
1887/115167
doi
10.1002/path.4877